Solco Healthcare US Valsartan recalled over manufacturing violations
- Recall date
- July 13, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Prinston Pharmaceutical Inc recalls Solco Healthcare US Valsartan, USP, 320 MG Tablets, 90-count bottle,Rx Only Manufactured by: Zhejiang Huahai Pharmaceut…
- Recall number
- D-0971-2018
- FDA classification
- Class II
- Brand / firm
- Prinston Pharmaceutical Inc
- Sold / distributed
- United States
Why it was recalled
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Solco Healthcare US Valsartan, USP, 320 MG Tablets, 90-count bottle,Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 USA NDC 43547-370-09
Get recall alerts
Free email alert whenever Prinston Pharmaceutical Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Prinston Pharmaceutical Inc